Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Harmony Biosciences Holdings (HRMY) Preferred Dividend Payments (2019 - 2020)

Historic Preferred Dividend Payments for Harmony Biosciences Holdings (HRMY) over the last 2 years, with Q3 2020 value amounting to $6.0 million.

  • Harmony Biosciences Holdings' Preferred Dividend Payments fell 3338.87% to $6.0 million in Q3 2020 from the same period last year, while for Dec 2020 it was $26.9 million, marking a year-over-year change of. This contributed to the annual value of $26.9 million for FY2020, which is 2363.54% down from last year.
  • Harmony Biosciences Holdings' Preferred Dividend Payments amounted to $6.0 million in Q3 2020, which was down 3338.87% from $10.4 million recorded in Q2 2020.
  • Harmony Biosciences Holdings' 5-year Preferred Dividend Payments high stood at $10.4 million for Q2 2020, and its period low was $6.0 million during Q3 2020.